Raj Kamal Rolston, MD
Affiliations: | Pathology | Geisinger Medical Center |
Area:
Alzheimer disease and agingWebsite:
http://www.geisingermedicallabs.com/directory/rolston.cfmGoogle:
"Raj Rolston"Bio:
http://www.curehunter.com/public/authorSummary-Rolston,%20Raj.do
Mean distance: 18.77 (cluster 28) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Clark TA, Lee HP, Rolston RK, et al. (2010) Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease. International Journal of Biomedical Science : Ijbs. 6: 225-227 |
Castellani RJ, Rolston RK, Smith MA. (2010) Alzheimer disease. Disease-a-Month : Dm. 56: 484-546 |
Rolston RK, Perry G, Zhu X, et al. (2009) Iron: A Pathological Mediator of Alzheimer Disease? Agro Food Industry Hi-Tech. 19: 33-36 |
Friedlich AL, Rolston RK, Zhu X, et al. (2009) Treatment advances in Alzheimer's disease based on the oxidative stress model. F1000 Medicine Reports. 1 |
Castellani RJ, Nunomura A, Rolston RK, et al. (2008) Sublethal RNA oxidation as a mechanism for neurodegenerative disease. International Journal of Molecular Sciences. 9: 789-806 |
Casadesus G, Rolston RK, Webber KM, et al. (2008) Menopause, estrogen, and gonadotropins in Alzheimer's disease. Advances in Clinical Chemistry. 45: 139-53 |
Rolston RK, Perry G, Zhu X, et al. (2008) Iron A pathological mediator of Alzheimer disease? Agro Food Industry Hi-Tech. 19: 33-36 |
Liu Q, Xie F, Rolston R, et al. (2007) Prevention and treatment of Alzheimer disease and aging: antioxidants. Mini Reviews in Medicinal Chemistry. 7: 171-80 |
Liu G, Men P, Harris PL, et al. (2006) Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neuroscience Letters. 406: 189-93 |